EP Patent

EP1432408B1 — Pharmaceutical compositions comprising colloidal silicon dioxide

Assigned to Novartis Pharma GmbH · Expires 2010-10-27 · 16y expired

What this patent protects

A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight.

USPTO Abstract

A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight.

Drugs covered by this patent

Patent Metadata

Patent number
EP1432408B1
Jurisdiction
EP
Classification
—
Expires
2010-10-27
Drug substance claim
No
Drug product claim
No
Assignee
Novartis Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.